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Gaucher disease results from an autosomal recessive deficiency of the lysosomal enzyme glucocerebrosidase. The
glucocerebrosidase gene is located in a gene-rich region of 1q21 that contains six genes and two pseudogenes within
75 kb. The presence of contiguous, highly homologous pseudogenes for both glucocerebrosidase and metaxin at
the locus increases the likelihood of DNA rearrangements in this region. These recombinations can complicate
genotyping in patients with Gaucher disease and contribute to the difficulty in interpreting genotype-phenotype
correlations in this disorder. In the present study, DNA samples from 240 patients with Gaucher disease were
examined using several complementary approaches to identify and characterize recombinant alleles, including direct
sequencing, long-template polymerase chain reaction, polymorphic microsatellite repeats, and Southern blots.
Among the 480 alleles studied, 59 recombinant alleles were identified, including 34 gene conversions, 18 fusions,
and 7 downstream duplications. Twenty-two percent of the patients evaluated had at least one recombinant allele.
Twenty-six recombinant alleles were found among 310 alleles from patients with type 1 disease, 18 among 74
alleles from patients with type 2 disease, and 15 among 96 alleles from patients with type 3 disease. Several patients
carried two recombinations or mutations on the same allele. Generally, alleles resulting from nonreciprocal recom-
bination (gene conversion) could be distinguished from those arising by reciprocal recombination (crossover and
exchange), and the length of the converted sequence was determined. Homozygosity for a recombinant allele was
associated with early lethality. Ten different sites of crossover and a shared pentamer motif sequence (CACCA)
that could be a hotspot for recombination were identified. These findings contribute to a better understanding of
genotype-phenotype relationships in Gaucher disease and may provide insights into the mechanisms of DNA
rearrangement in other disorders.
Introduction
In mammalian cells, DNA rearrangement occurs by chro-
mosomal pairing, breakage, and crossover between two
nonsister chromatids during meiosis and is an essential
cellular process. However, recombination between ho-
mologous sequences of DNA may also introduce harmful
mutations resulting from the unequal pairing of chro-
mosomes. The frequency of nonequal chromosomal pair-
ing and DNA rearrangement is influenced by the degree
of DNA sequence homology that exists between corre-
sponding segments on the two chromosomes. The oc-
currence of homologous recombination can be enhanced
by the presence of highly repetitive DNA sequence fam-
ilies, low-copy repeats, a processed or nonprocessed pseu-
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dogene sequence, or the duplication of a region within
the locus (Chen et al. 1997; Purandare and Patel 1997;
Strachan andRead 1999; Stankiewicz and Lupski 2002a).
Misalignment and recombination of homologous se-
quences cause DNA rearrangements that lead to genetic
disorders and include deletions, duplications, inversions,
fusions, and gene conversions (Mazzarella and Schlessin-
ger 1998; Emanuel and Shaikh 2001; Hurles 2001; Inoue
et al. 2001; Stankiewicz and Lupski 2002b). Human dis-
orders resulting from DNA rearrangements due to struc-
tural features of the genome have been referred to as
“genomic disorders” (Lupski 1998). Analyzing the results
of homologous recombination in human genes can pro-
vide insights into the mechanisms of DNA rearrangement
and may also enhance our understanding of factors con-
tributing to the complexity seen in specific disorders. In
the present study, we have evaluated the frequency and
possible phenotypic consequences of crossover events and
gene conversion occurring between the glucocerebrosi-
dase (GBA) gene and its nonprocessed pseudogene located
on the same chromosome.
The human GBA gene (GenBank accession number
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J03059), located on chromosome 1q21, has a pseudo-
gene (GenBank accession number J03060) that shares
96% exonic sequence homology, located 16 kb down-
stream of the functional gene (Horowitz et al. 1989;
Winfield et al. 1997). The 1q21 region is gene rich, with
seven genes and two pseudogenes located in close prox-
imity (GenBank accession number AF023263) (Winfield
et al. 1997). The gene for metaxin (MTX) is located
immediately downstream of the GBA pseudogene and
is convergently transcribed, encoding a protein of 317
amino acids that appears to be part of a preprotein
import complex in the outer membrane of mitochondria
(Armstrong et al. 1997). MTX also has a pseudogene
located between the GBA gene and pseudogene, im-
mediately adjacent to the 3′ end of the functional GBA
gene (Long et al. 1996). These genes can serve as a
model to demonstrate the effects of unequal pairing and
recombination on gene function.
Gaucher disease (MIM 230800), the autosomal reces-
sive inherited deficiency of lysosomal glucocerebrosidase
(EC 3.2.1.45), presents with many diverse clinical phe-
notypes (Stone et al. 2000; Beutler andGrabowski 2001).
On the basis of the presence and rate of progression of
neurological symptoms, Gaucher disease has been di-
vided into type 1 (nonneuronopathic), type 2 (acute neu-
ronopathic), and type 3 (subacute neuronopathic) forms.
The gene for glucocerebrosidase is organized into 11 ex-
ons coding for 498 amino acids, and, to date, 1200 dif-
ferent mutations have been identified (Beutler and Gel-
bart 1998; Hodanova et al. 1999; Koprivica et al. 2000;
Orvisky et al. 2002; GeneDis Databank). Studies of ge-
notype-phenotype correlation indicate that clinically sim-
ilar patients have many different genotypes and that pa-
tients sharing the same PCR-defined point mutations can
have a spectrum of clinical manifestations (Koprivica et
al. 2000; Zhao and Grabowski 2002). Most mutations
resulting in Gaucher disease are point mutations that are
distributed throughout the gene, with a majority clus-
tered between exons 8 and 11. Several missense muta-
tions, particularly N370S and L444P, are encountered
with an increased frequency. Other mutations include
frameshifts, deletions (with or without insertions), and
splice-site mutations.
Another important group of mutations result from
homologous recombination between the GBA gene and
pseudogene. Patients with a recombinant allele con
taining three single point mutations—two that intro-
duce the amino acid substitutions L444P and A456P,
and a silent mutation, V460V, in exon 10 (Rec NciI)—
were first reported in 1990 (Eyal et al. 1990; Latham
et al. 1990). This allele is referred to as “recombinant
1” (Rec 1) in the present study. Subsequently, another
recombinant allele was described, encompassing the
same three changes with an additional amino acid sub-
stitution, D409H, in exon 9 (Rec TL or Rec 2) (Eyal et
al. 1990; Zimran and Horowitz 1994). Homologous
recombination resulting in a fusion that includes the 5′
segment of the GBA functional gene extending from
exon 1 to intron 9, with the remainder of the sequence
corresponding to the pseudogene, was shown by Zim-
ran et al. (1990). Strasberg et al. (1994) first reported
homozygosity for a recombinant allele in a patient with
lethal type 2 Gaucher disease. Another type of mutant
allele, a 55-bp deletion in exon 9 resulting from gene
conversion from the pseudogene sequence, has also been
reported (Walley and Harris 1993; Beutler et al. 1995;
Tayebi et al. 1996b). Furthermore, recombinant alleles
that include the 55-bp deletion, D409H, L444P, A456P,
and V460V (Rec 3) have been identified, in which the
site of crossover is located within the region extending
from the end of intron 8 to the beginning of exon 9
(Hatton et al. 1997; Tayebi et al. 1998). Several reports
have described fusion alleles in which the recombination
occurred in the upstream portion of the gene, including
introns 2, 3, and 6, introducing a larger segment of
pseudogene into the recombinant allele (Reissner et al.
1998; Cormand et al. 2000; Filocamo et al. 2000). Pa-
tients with a crossover site in the 3′ UTR of the GBA
gene or the adjacent MTX pseudogene have also been
identified (Stone et al. 2000; Tayebi et al. 2000, 2001).
To improve upon previous genotype-phenotype
studies, we performed detailed molecular analyses of
the GBA gene mutations in 480 alleles from clinically
diverse patients with Gaucher disease. Because the high
sequence homology between genes and pseudogenes at
this locus increases the likelihood of recombination,
we set out to determine the frequency, type, location,
and mechanisms of recombination and whether dif-




DNA samples from 240 patients with Gaucher dis-
ease were analyzed, including 155 patients with type
1, 37 patients with type 2, and 48 patients with type
3 Gaucher disease. Medical records were reviewed.
DNA was also collected from selected family members.
The patients and relatives provided informed consent
through a protocol approved by the National Institute
of Mental Health institutional review board. The series
also included several cell lines purchased from the Na-
tional Institute of General Medical Sciences Human
Genetic Mutant Cell Repository.
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DNA Preparation
High-molecular-weight DNA was isolated from lym-
phocytes, cultured fibroblasts, and/or EBV transformed
lymphoblast cell lines from normal, affected, and carrier
individuals, by standard protocols (Sambrook et al.
1989).
Mutation Analysis
Genomic DNA samples were screened for five com-
mon point mutations—N370S, L444P, R463C, c.84-
85insG, and IVS21GrA—and the 55-bp deletion,
through use of PCR, the amplification refraction mu-
tation system (ARMS), restriction-enzyme digestion, and
direct sequencing methods, as described by Mistry et al.
(1992) and Tayebi et al. (1996a, 1997). After this screen-
ing, DNA from any patient with an unidentified muta-
tion, a homozygous genotype, or a mutant allele that
derived from pseudogene sequence was subjected to fur-
ther analysis.
To confirm the presence of the mutations identified
by screening and to search for unknown mutations,
each of the 11 exonic regions of the GBA gene, in-
cluding flanking intronic sequences and a 1-kb frag-
ment of the 5′ UTR, were selectively amplified using
PCR primers that were designed to amplify the func-
tional GBA gene but not the pseudogene (Reissner et
al. 1998; Stone et al. 2000). Direct sequencing of the
PCR products in both directions was performed by cy-
cle sequencing using the fluorescent dideoxy termina-
tion method according to standard protocols. Fluoro-
metric sequences were analyzed using the 373A DNA
Sequencer (Applied Biosystems).
Long-template PCR was performed in selected cases,
as described by Tayebi et al. (1996a, 1998). The bands
corresponding to the recombinant alleles were isolated
and sequenced to confirm the recombination and the site
of crossover.
Southern Blot Analyses
Genomic DNA (10–15 mg) was isolated from patients
and normal control individuals and was digested over-
night at 37C with the restriction enzymes SstII, SspI,
EcoRI, or HincII. The digested DNAs were electropho-
resed on a 0.6% I.D.NA (FMC Bioproducts) agarose gel
for 16–18 h (for SspI and HincII) or for 40–48 h (for
the restriction enzymes SstII and EcoRI). The gels were
transferred to a supported nitrocellulose filter (Schleicher
and Schuell) and were hybridized with 32P-labeled GBA
cDNA or MTX cDNA probes.
In addition, Southern blots prepared with HincII-
digested DNA were hybridized to three shorter GBA
cDNA probes. The first probe was a 250-bp fragment
encompassing exons 2–4, which was amplified using the
forward primer 5′-CAGGCAGTGTCGTGGGCATC-3′
and the reverse primer 5′-CAGAACAGAAGTTCCAG-
AAA-3′ (annealing temperature 60C). A second probe,
a 476-bp fragment covering exons 4–7, was amplified
with the forward primer 5′-CTGCTGCTCTCAACATC-
CTT-3′ and the reverse primer 5′-TGTTGAGTGGATA-
CCCCTTC-3′ (annealing temperature 60C), and a third
762-bp fragment, containing exons 7–11, was amplified
using the forward primer 5′-TTCCTGGATGCCTATG-
CTGA-3′ and the reverse primer 5′-GCTCCTCTAAGG-
ATGTCCC-3′ (annealing temperature 60C). Southern
blots of HincII-digested DNA were also hybridized to
an MTX cDNA probe.
Analysis of Polymorphic Sites
Genotypes at two polymorphic microsatellite sites, a
dinucleotide (CT) repeat located upstream of the GBA
gene and a tetranucleotide (AAAT) repeat located down-
stream of the GBA gene, were determined as described
by Lau et al. (1999).
Analysis of Motif Sequences
To identify DNA regions representing shared motif
sequences at specific crossover sites in the GBA gene, all
sequences surrounding the approximate sites of recom-
bination were aligned using the GCG and Sequencher
software programs (Gene Codes).
Nomenclature for Recombinant Alleles
The approximate initiation point for a gene conver-
sion or reciprocal recombination event was determined
by examination of known mismatches between the func-
tional gene and pseudogene sequences. The crossover
region was defined as the sequence between the last mis-
match corresponding to the functional GBA gene and
the first mismatch corresponding to pseudogene. In the
case of gene conversions, the length of converted se-
quence was determined by identifying where the func-
tional gene sequence resumed.
The different recombinant alleles are referred to as
Rec 1–7, depending upon the exonic site at which pseu-
dogene sequence was first detected (table 1). Recombi-
nant alleles resulting from a nonreciprocal event such as
gene conversion are further defined with an “a.” These
alleles carried only a small converted segment originat-
ing from the pseudogene (table 2). Recombinant alleles
resulting from reciprocal recombination are designated
with a “b” (table 3). These alleles may carry either a
fusion between the gene and pseudogene or a duplicated
allele.
The site at which conversion begins in the “a” group
can be similar to the site of crossover observed in the
“b” group (tables 1, 2, and 3). For example, although
Rec 1a and Rec 1b both have sequence in exon 10 de-
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Table 1
Recombinant Alleles Resulting from Crossover or Gene Conversion between the GBA Gene and Pseudogene
Recombination Description
Rec 1a or b The allele carries mutations L444P, A456P, and V460V. Crossover sites include Ex9-Int-9, Int-9 or Int9-Ex10.
(See fig. 1e, 1f, and 1g).
Rec 2a or b The allele carries mutations D409H, L444P, A456P, and V460V. Crossover site is in Ex9. (See fig. 1d).
Rec 3a or b The allele carries the 55-bp deletion in exon 9, as well as point mutations D409H, L444P, A456P, and V460V.
Crossover site is in the Int8-Ex9 region (see fig. 1c).
Rec 4a or b The allele carries pseudogene sequence beginning from intron 3. Crossover site is in Int3 (see fig. 1a).
Rec 5a or b The allele carries the pseudogene sequence beginning from intron 4. Crossover site is in Int4 (see fig. 1b).
Rec 6a or b The allele carries the pseudogene sequence beginning from intron 10 or has a duplicated pseudogene
with a fusion between metaxin and pseudometaxin. Crossover site is in the Int10-Ex11 region (see fig. 1h).
Rec 7a or b The allele carries the pseudogene sequence beginning from the 3′ UTR or has a duplicated pseudogene with a
fusion between MTX and pseudometaxin. Crossover site is in the 3′ UTR (see fig. 1i) or in MTX.
rived from the pseudogene, Rec 1a results from a gene
conversion and Rec 1b is a fusion allele. Because the
beginning and extent of a crossover or gene conversion
can be detected only by the identification of pseudogene
sequence that is not homologous to that of the functional
gene, the location of the initiation of the recombination
is not exact. Although seven different groups of recom-
binations are defined, 10 different sites of recombination
are described, as shown in figure 1.
Results
We analyzed 480 alleles from 240 patients with Gaucher
disease. This analysis included mutation detection and
total and/or partial sequencing of the 11 exons and
flanking intronic regions in 422 alleles. In ∼20% of these
alleles, the sequencing focused on the region from exon
8 to exon 11, whereas, for the rest, the entire gene was
sequenced. All patients with mutation L444P or any
other pseudogene-derived mutation were analyzed by
Southern blots. Moreover, patients with a homozygous
genotype were examined by long PCR template and/or
Southern blots, and, when possible, parental DNA was
studied to exclude the possibility of a deletion on one
allele. The final result was the identification of 59 re-
combinant alleles, representing 12% of the alleles stud-
ied, and the type, frequency, and distribution of recom-
binant alleles among patients with different types of
Gaucher disease are summarized in table 4. Twenty-two
percent of the patients evaluated had at least one re-
combinant allele present. However, since Southern blots
and full sequencing were not performed on every pro-
band, this may be an underrepresentation of the total
number.
Sequencing data showed that a significant number of
the patients with point mutations previously identified
by PCR screening for individual mutations actually car-
ried recombinant alleles with more than one point mu-
tation derived from the pseudogene sequence. The se-
quence was examined carefully, focusing on every site
at which the sequence for the gene and pseudogene were
known to differ, and the length of the pseudogene/func-
tional gene substitutions and the site of crossover or
gene conversion were estimated (tables 1, 2, and 3).
To pinpoint the crossover site and the type of recom-
bination for the remaining recombinant alleles, long
PCR results and Southern blot analyses were examined.
Long PCR indicated that several patients had smaller
fusion alleles. The fusion alleles detected by this method
resulted from recombination between the GBA gene and
its pseudogene, with crossover sites located in the 5′
regions of the gene. Since the GBA pseudogene has large
deletions in introns 2, 4, 6, and 7 (Horowitz et al. 1989),
long PCR demonstrates two separate bands, which rep-
resent the normal allele (6.6 kb) and a shorter recom-
binant allele (∼5 kb). By examining the long PCR re-
sults, two fusion alleles, designated as “Rec 4b” and
“Rec 5b” (table 3; patients 13 and 17), were identified
with a crossover in the 5′ region of the gene. Sequencing
of the mutant band demonstrated the specific crossover
sites.
In general, alleles with reciprocal recombinations in-
cluding fusions and duplications could be detected by
Southern blots using the restriction enzymes SstII, SspI,
and EcoRI (fig. 2A, 2B, and 2C). On the other hand,
recombinations resulting from gene conversion had a
normal pattern on Southern blots. The restriction en-
zyme HincII, which cleaves at several sites within the
GBA gene but not the pseudogene (fig. 2D), was used
to localize the crossover region. Three short probes
(from exons 2–4, 4–7, and 7–11) were hybridized to
Southern blots of HincII-digested DNA, which enabled
the identification of the site of crossover in better detail
in some cases.
Alleles Resulting from Gene Conversion Events
Table 2 summarizes the molecular and clinical data
in patients with type 1, 2, and 3 Gaucher disease who
had gene conversion events or nonreciprocal recombi-
Table 2


















(bp) Southern Blot Results Clinical Features
Type 1:
1 European American 2/3 N370S/Rec 1a Ex9-Int9 824 Normal Hepatosplenomegaly, anemia, thrombocytopenia
2 Ashkenazi NA N370S/c.1263-1317del-a Int8-Ex9 288 Missing exon 9 site on HincII Hepatosplenomegaly, anemia, thrombocytopenia
3 Hispanic 13/48 N370S/Rec 1a Ex9-Int9 824 Normal Splenectomy, hepatomegaly, bone disease
4 African American 14/15 c.222-224delTAC/Rec 1aRec 6b Ex9-Int9 824 Pseudogene duplication Hepatosplenomegaly, anemia, thrombocytopenia
5 Hispanic 10/34 N370S/Rec 1a Ex9-Int9 824 Normal Splenectomy, hepatomegaly, bone disease
6 European American 4/8 N370S/c.1263-1317del-a Int8-Ex9 288 Missing exon 9 site on HincII Hepatosplenomegaly
7 African American 2/5 V352L/Rec 1aRec7b Ex9-Int9 824 Pseudogene duplication Splenectomy, hepatomegaly
8 European American 6/21 N370S/Rec 1a Int9-Ex10 475 Normal Hepatosplenomegaly, thrombocytopenia, bone disease
9 European American 8/28 N370S/L444Pa Int9 194 Normal Splenectomy, hepatomegaly, bone disease
10 French NA N370S/Rec 1a Int9 824 Normal Parkinsonism
11 African American 1/1 N117D/Rec 1a Int9-Ex10 424 Normal Splenectomy, bone disease, hepatomegaly, anemia, thrombocytopenia
12 European American 13/16 N370S/Rec 1a Ex9-Int9 824 Normal Hepatosplenomegaly, thrombocytopenia
13 NA NA N370S/c.1263-1317del-a Int8-Ex9 288 NA NA
14 French 24 N370S/c.1263-1317del-a Int8-Ex9 288 Missing exon 9 site on HincII Thrombocytopenia, splenectomy, parkinsonism
15 NA NA N370S/Rec 1a Ex9–Int9 824 Normal NA
Type 2:
16 European American 5 mo L444P/Rec 1a Int9-Ex10 424 Normal Hepatosplenomegaly, seizures
17 Greek Birth H225Q/Rec 3a Int8-Ex9 849 Normal Hepatosplenomegaly, seizures, opisthotonus
18 NA Birth Rec 1a/Rec la Ex9-Int9 824 Normal Hydrops
19 Lebanese Birth Rec 1a/Rec 1a Ex9-Int9 824 Normal Hydrops
20 Australian Birth R257Q/c.1263-1317del-a Int8-Ex9 288 Normal Ichthyosis, hepatosplenomegaly
21 European American Birth Rec 2a/Rec 2a Ex9 1193 Missing exon 9 site on HincII Hydrops
22 European American NA L444P/Rec 1a Int9-Ex10 424 Normal NA
23 European American NA R285H/c. 1263-1317del-a Int8-Ex9 288 Missing exon 9 site on HincII NA
24 European American 11 mo L444P/Rec 1a Ex9-Int9 824 Normal Hepatosplenomegaly, seizures, opisthotonus
Type 3:
25 European American 1/6 D409H/Rec 1a Ex9-Int9 824 Normal Hepatosplenomegaly, cardiac fibrosis, abnormal horizontal saccades
26 European American 4/28 F216Y/c.1263-1317del-a Int8-Ex9 288 Missing exon 9 site on HincII Renal disease, bone disease, myoclonic epilepsy
27 European American 4/13 R463C/Rec 1aRec7b Ex9-Int9 824 Pseudogene duplication Abnormal horizontal saccades, splenectomy, hepatomegaly, bone
disease
28 Ashkenazi/Sephardic 5/9 V394L/Rec 1a Int9-Ex 10 824 Normal Abnormal horizontal saccades, hepatosplenomegaly, myoclonic
epilepsy, developmental delay, lung disease
29 African American 38/40 N188S/Rec 1a Int9-Ex10 824 Normal Hepatosplenomegaly, abnormal horizontal saccades, myoclonic
epilepsy
30 French 1/4 V394L/Rec 1a Int9-Ex10 824 Normal Hepatosplenomegaly, abnormal horizontal saccades, myoclonic
epilepsy, developmental delay
31 Mexican 4/6 F213I/L444Pa Ex9-Int9 510 Normal Hepatosplenomegaly, abnormal horizontal saccades, myoclonic
epilepsy, developmental delay
NOTE.—NA p not available.
a Alleles discussed in this table are underlined.
b Refer to figure 1 for precise description of sites.
Table 3
Genotype/Phenotype Data on Patients with an Allele Resulting from Reciprocal Recombination
Disease Type and




(years) Genotypea Site of Crossoverb Southern Blot Results Clinical Features
Type 1:
1 European American 1/12 N370S/Rec 2b Ex9 Fusion Hepatosplenomegaly, anemia, thrombocytopenia
2 African American 2/5 R170C/L444PRec 7b 3′ UTR or MTX Pseudogene duplication Hepatosplenomegaly, anemia, thrombocytopenia,
bone disease
3 European American 3/18 R463C/Rec 1b Ex9-Int9 Fusion Splenectomy, hepatomegaly, thrombocytopenia, renal
disease
4 European American 1/7 N370S/Rec 1b Int9-Ex10 Fusion Hepatosplenomegaly
5 African American 14/15 c.222-224delTAC/Rec 1aRec 6b Int10-Ex11 Pseudogene duplication Hepatosplenomegaly, anemia, thrombocytopenia
6 African American 2/5 V352L/Rec 1aRec 7b 3′ UTR or MTX Pseudogene duplication Splenectomy, hepatomegaly, bone disease
7 African American 13/22 c.153-154insTACAGC/Rec 1b Ex9-Int9 Fusion Hepatosplenomegaly, anemia, thrombocytopenia,
bone disease
8 NA NA N370S/Rec 1b Ex9-Int9 Fusion NA
9 European American 30/30 N370S/Rec 3b Int8-Ex9 Fusion Hepatosplenomegaly, bone disease,
thrombocytopenia
10 European American 5/28 N370S/Rec 1b Int9-Ex10 Fusion Hepatosplenomegaly, thrombocytopenia
11 European American 10/21 R463C/Rec 1b Ex9-Int9 Fusion Splenectomy, anemia, thrombocytopenia, liver disease
Type 2:
12 European American 6 mo R257Q/L444PRec 6b Int10-Ex11 Fusion Hepatosplenomegaly, seizures
13 Ashkenazi Fetus IVSl02TrG/Rec 4b Int3 Fusion Hydrops
14 African American 8 mo E41K/Rec 1b Int9 Fusion Hepatosplenomegaly, seizures, developmental delay
15 European American NA Rec 1b/Rec 1b Ex9-Int9 Fusion NA
16 Mexican NA L444PE326K/L444PRec 7b MTX Fusion in MTX Hepatosplenomegaly, opisthotonus
Type 3:
17 Korean 22/22 N188S/Rec 5b Int4 Fusion Myoclonic epilepsy
18 European American 3/13 R463C/Rec 1b Ex9-Int9 Fusion Hepatosplenomegaly, abnormal horizontal saccades
19 European American 4/13 R463C/Rec 1aRec 7b 3′ UTR or MTX Pseudogene duplication Hepatomegaly, abnormal horizontal saccades,
splenectomy, bone disease
20 European American 18/45 L444P/D409HRec 7b MTX Pseudogene duplication Parkinsonism, splenectomy
21 European American 7/28 N188S/Rec 1b Int9-Ex10 Fusion Abnormal horizontal saccades, myoclonic epilepsy,
dementia
22 European American 5/9 R463C/Rec 1b Ex9-Int9 Fusion Hepatomegaly, splenectomy, lung disease, bone
disease, abnormal horizontal saccades
23 European American 1/1 L444P/L444PRec 7b 3′ UTR or MTX Pseudogene duplication Hepatosplenomegaly, abnormal horizontal saccades,
developmental delay
24 European American 1/4 G202R/L444PRec 7b 3′ UTR or MTX Pseudogene duplication Abnormal horizontal saccades, developmental delay,
myoclonic epilepsy
NOTE.—NA p not available.
a Alleles discussed in this table are underlined.
b Refer to figure 1 for precise description of sites.
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Figure 1 Recombination initiation sites and allele frequencies. The initiation regions for recombination events were determined by
comparing mismatches between the GBA functional gene and pseudogene sequences. The region where a recombination starts is defined as
the sequence between the last mismatch containing functional gene sequence and the first mismatch carrying pseudogene sequence. The
schematics show the exonic structure of GBA, with the different initiation regions indicated in gray, with arrows below. The number of
alleles found in patients with type 1, 2, or 3 Gaucher disease with either reciprocal or nonreciprocal recombinations starting within the
given region are shown next to each schematic map. The abbreviations for each initiation region are used in tables 1, 2, and 3. a, Int3; the
recombination starts within 26 bp in intron 3. b, Int4; the recombination starts within 98 bp in intron 4. c, Int8-Ex9; the recombination
starts within 288 bp encompassing the intron 8/exon 9 junction. d, Ex9; the recombination starts within 23 bp of exon 9 following the 55
bp that are deleted in pseudogene. e, Ex9-Int9; the recombination starts within 186 bp encompassing the exon 9/intron 9 junction. f, Int9;
the recombination starts within 30 bp at the end of intron 9. g, Int9-Ex10; the recombination starts within 126 bp encompassing the intron
9/exon 10 junction. h, Int10-Ex11; the recombination starts within 300 bp encompassing the intron 10/exon 11 junction. i, 3′ UTR; the
recombination starts within 304 bp in the 3′ UTR. j, MTX (not shown); the recombination starts within the MTX pseudogene.
nations. Thirty-four (58%) of the 59 recombinant alleles
fell in this category, including 58% of all recombinant
alleles in patients with type 1, 67% in patients with type
2, and 47% in patients with type 3 (table 4). A wide
range of mutations was encountered on the second allele,
as shown in table 2. In all 31 patients with these alleles,
the site of gene conversion appeared to begin between
exon 8 and intron 9 (fig. 1). It is possible that the gene
conversion data is an underestimate, since not all in-
tronic regions and, in some cases, not all of the 5′ exonic
regions were sequenced. For the recombinant alleles in
table 2, the maximum possible length of the converted
sequence ranged between 194 bp and 1,193 bp. The
Southern blot results for this group were normal except
for the six patients who carried the 55-bp deletion in
exon 9, where a HincII site is lost (see representative
example, fig. 2D). There were two alleles carrying L444P
(table 2; patients 9 and 31), in which the mutation ap-
pears to have resulted from a gene conversion event and
not as an individual point mutation, since pseudogene
526 Am. J. Hum. Genet. 72:519–534, 2003
Table 4
















NO. OF ALLELES FOR EACH
TYPE OF RECOMBINATION
Gene Conversion Fusion Duplication
1 155/310 24 (16) 26 (8) 15 8 3
2 37/74 14 (38) 18 (24) 12 6 0
3 48/96 14 (29) 15 (16) 7 4 4
Total 240/480 52 (22) 59 (12) 34 18 7
a Several patients had more than one recombination on the same allele.
sequence was also present in intron 9. Patient 9, with
type 1 disease, carried only one pseudogene mismatch,
whereas patient 31, with type 3 disease, had two sites
corresponding to pseudogene sequence in intron 9.
Alleles Resulting from Reciprocal Recombination
Table 3 describes the alleles resulting from reciprocal
recombination that carried either a fusion between the
GBA gene and pseudogene or a duplication. For each
of the 25 alleles identified (42% of all recombinants),
Southern blots using the four restriction enzymes con-
firmed the reciprocal recombination (see fig. 2 for rep-
resentative examples). Reciprocal recombinations were
found in 42% of recombinant alleles from patients with
type 1, 33% from patients with type 2, and 53% from
patients with type 3 disease (table 4).
Seven alleles carried a duplication of the GBA pseu-
dogene and a fusion between the MTX gene and pseu-
dometaxin, resulting from a crossover at the 3′ region
of the gene (Tayebi et al. 2000). The site of crossover
was identified by sequencing and by Southern blots using
the restriction enzymes HincII and EcoRI (fig. 2C and
2D). In three of these patients, the presence of a dupli-
cation was confirmed through studies of the tetranucle-
otide repeat polymorphism ITG6.2, located in the region
between the GBA gene and pseudogene. In these indi-
viduals, three allelic forms (318 bp, 322 bp, and 326
bp) were found. The site of crossover for these recom-
binant alleles was pinpointed by sequencing and is re-
ferred to as “Rec 6b” (crossover initiates between Int10
and Ex11) or “Rec 7b” (crossover within a 304-bp se-
quence at the 3′ UTR or between MTX and pseudo-
metaxin). Southern blots prepared usingHincII-digested
DNA were also hybridized to an MTX cDNA probe
(data not shown). The results confirmed the duplication
and fusion alleles found in the 3′ region.
Although 18 fusion alleles were identified, the size of
the fusion product seen on the Southern blots varied
because of different sites of crossover (fig. 2). The sites
were mostly clustered between intron 8 and exon 11 of
the GBA gene, with the exception of two alleles in which
the site of crossover was in intron 3 (table 3, patient 13)
or intron 4 (table 3, patient 17) and two unique fusion
alleles resulting from crossovers within intron 10 to exon
11 or within pseudometaxin (table 3, patients 12 and
16). The latter two alleles both had fusions between the
MTX gene and pseudogene. One patient (table 3, patient
15) was homozygous for a fusion allele in which the site
of crossover occurred within the last 186 bp of exon 9
or in the beginning of intron 9. Homozygosity for a
fusion allele has not previously been reported. Among
the patients with reciprocal crossover, there was also a
wide range of mutations present on the second allele.
Nine alleles with a reciprocal recombination in the 3′
region of the GBA gene, two with fusions and seven
with duplications, also carried a point mutation or an-
other recombinant allele. An analysis of parental DNA
showed that the 3′ region recombinations (Rec 6b and
Rec 7b) were located on the allele with L444P or Rec
1a, except for one case (table 3; patient 20) in which
Rec 7b and D409H were on the same allele. To deter-
mine which was the original mutation on these alleles
and whether the first mutation increases the likelihood
of a second mutation, studies of several successive gen-
erations will be needed.
Sites of Recombination and Motif Sequences
The examination of the 59 recombinant alleles by
Southern blots and detailed sequencing led to the iden-
tification of 10 different sites of crossover or gene con-
version. An accurate identification of the site where the
crossover event occurred was dependent upon the degree
of gene/pseudogene homology in a specific region. Seven
of the 10 sites were located between intron 8 and the 3′
UTR (fig. 1).
The sequences within the regions surrounding the 10
sites were compared to identify one or more possible
motif sequences that might predispose to crossover. A
pentamer sequence (CACCA) was found in five of the
crossover regions and was identified in 35 of 59 recom-
binant alleles. A similar tetramer sequence (CACC) was
found at two additional sites in 11 patient alleles. The
remaining two sites without this sequence shared a dif-
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Figure 2 Southern blots of the GBA gene and pseudogene. Genomic DNAs were digested using four different restriction enzymes and were
hybridized to a human GBA cDNA probe. A representative selection of patients with different recombinant alleles is shown in each panel. Included
are schematic maps showing the normal restriction sites. Samples in each lane are identified by the table, patient number, and the recombinant
allele they demonstrate (i.e., T2-2, Rec 7b is table 2, patient 2 with Rec 7b). The approximate sizes of the abnormal bands are shown to the right
of each blot. A, SstII-digested DNA samples: lane 1, normal control demonstrating a single 46-kb band; lane 2, T3-2, Rec 7b; lane 3, T3-20, Rec
7b; lane 4, T3-13, Rec 4b; and lane 5, T3-14, Rec 1b. B, SspI-digested DNA samples: lane 1, normal control with 17- and 12-kb bands; lane 2,
T3-11, Rec 1b; lane 3, T3-1, Rec 2b; lane 4, T3-20, Rec 7b; lane 5, T2-20, c.1263-1317del-a; and lane 6, T3-17, Rec 5b. C, EcoRI-digested DNA
samples: lane 1, normal control with 14- and 12.7-kb bands; lane 2, T3-24, Rec 7b; lane 3, T3-12, Rec 6b; lane 4, T3-13, Rec 4b; and lane 5, T3-
14, Rec1b. D, HincII-digested DNA samples: lanes 1, 6, and 8, normal controls showing 21-, 18-, 5.2-, 2.7-, and 0.9-kb bands; lane 2, T3-16,
Rec7b; lane 3, T3-11, Rec 1b; lane 4, T2-5, Rec 1a; lane 5, T3-13, Rec 4a; lane 7, T2-20, c.1263-1317del-a; lane 9, T3-2, Rec 7b; and lane 10,
T3-5, Rec 6b.
ferent tetramer sequence (TGGG), which was found in
13 recombinant alleles.
Correlation with Clinical Data
The ethnic or racial backgrounds of patients carrying
recombinant alleles were quite varied. Of note, although
nine recombinant alleles were identified in 10 African
American patients with Gaucher disease, the recombi-
nations included both fusions and gene conversions, sug-
gesting that this was not due to a founder effect.
The majority of the 24 patients with type 1 Gaucher
disease carrying recombinant alleles had significant dis-
ease manifestations. Twenty-one of the subjects whose
clinical data were available were diagnosed by adoles-
cence, and a majority had hepatosplenomegaly and cy-
topenia. Eight had undergone splenectomy and seven
were described as having bone disease. Seventeen of these
patients had mutation N370S on their second allele. Al-
though the patients with genotype N370S/Rec had a wide
range of disease severity, the severity in those with re-
combinant alleles resulting from reciprocal recombina-
tion did not differ significantly from those with gene
conversions.
Among the 14 patients with type 2 Gaucher disease,
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nine had recombinant alleles resulting from gene con-
version. In the three cases in which there was homo-
zygosity for a gene conversion allele (table 2, patients
18, 19, and 21), death resulted from hydrops fetalis,
although the three patients did not all share the same
site of recombination. Three other patients with L444P/
Rec1a (table 2, patients 16, 22, and 24) lived for ap-
proximately one year. Of the five patients with fusion
alleles, one had a hydrops fetalis phenotype. This fetus
(table 3, patient 13) carried a fusion allele that resulted
from a crossover in intron 3, along with a splice site
mutation in exon 10 on the second allele. Another pa-
tient was found to be homozygous for a fusion allele
(table 3, patient 15). One infant with a classic type 2
phenotype had genotype L444P/L444P (table 3, patient
16), a genotype not normally associated with type 2
Gaucher disease. However, each L444P allele also had
a second alteration that might have a modifying effect
on the phenotype. One carried the presumed polymor-
phism E326K (Park et al. 2002a) and the other a 3′-
region duplication within the sequence for pseudome-
taxin (Rec 7b) (Tayebi et al. 2000).
Among the 14 patients with type 3 Gaucher disease
carrying recombinant alleles, six had a recombination re-
sulting from gene conversion, seven as a result of recip-
rocal recombination, and one patient had both types of
recombinant alleles. Clinically, patients with alleles re-
sulting from both reciprocal and nonreciprocal recom-
binations were similar, with a diagnosis in early childhood
in all but three patients. Of note, half of the subjects with
either type of recombinant allele had myoclonic epilepsy
associated with their other disease manifestations. Mu-
tation N188S was found together with recombinant al-
leles in three patients with type 3 Gaucher disease (table
2, patient 29; and table 3, patients 17 and 21). While
each of the three had a different recombinant allele, all
three patients were adults with uncontrolled myoclonic
epilepsy. The two patients with genotype V394L/Rec 1a
(table 2, patients 28 and 30) shared a similar phenotype,
with progressive myoclonic epilepsy in childhood. Three
patients with type 3 disease, one with R463C/Rec 1a (ta-
ble 2, patient 27) and two with R463C/Rec 1b (table 3,
patients 18 and 22), had aggressive visceral and skeletal
disease and slowing of the horizontal saccades as their
principal neurologic manifestation. However, two other
patients with R463C/Rec 1b (table 3, patients 3 and 11)
had a type 1 phenotype with no neurologic symptoms.
Discussion
Homologous recombination, both reciprocal and non-
reciprocal, has been implicated as the cause of mutations
in many human disorders. Repeated DNA sequences can
be one of the forces driving recombination and have been
classified on the basis of the location, distribution and
length of the repeat sequence, and the number of repeats
(Purandare and Patel 1997). Alu sequences, a specific
class of repeat sequences, are one of the major sources
of DNA rearrangement and are implicated in several
genetic disorders (Brooks et al. 2001; Martinez et al.
2001; Batzer and Deininger 2002; Lutskiy et al. 2002).
Another cause of recombination is the presence of du-
plicated gene sequences or “duplicons,” which can me-
diate local deletions, duplications, fusions, inversions,
and gene conversion (Ji et al. 2000; Eichler 2001). Du-
plicons can consist of tandemly repeated sequences or
low-copy repeat sequences (LCRs), including gene clus-
ters, gene fragments, pseudogenes, or repeat elements
flanking unique sequence. LCRs are usually 10–400 kb
in size and exhibit 95%–98% homology (Stankiewicz
and Lupski 2002a). The likelihood of DNA rearrange-
ment is increased when repeated fragments are located
near one another on the same chromosome but are not
directly adjacent. Recombinant alleles resulting in hu-
man disease can be categorized by the type of recom-
bination, either nonreciprocal or reciprocal. This dis-
tinction proved very useful in our characterization of
recombinations at the GBA gene locus.
The nonreciprocal exchange of homologous se-
quence, also known as gene conversion, has been ex-
tensively examined in lower eukaryotes, in which, un-
like mammalian systems, the results of meiosis can be
easily recovered and studied. In nonreciprocal genetic
exchange, the transient pairing of two similar, although
not identical, genes or alleles is followed by conversion
of one sequence to that of the other. The donor sequence
is not changed, but the acceptor sequence is altered by
the incorporation of sequence copied from the donor
sequence (fig. 3A) (Strachan and Read 1999).
In general, gene conversion results from nonrecipro-
cal sequence exchange between either nonallelic or al-
lelic DNA sequences. Gene conversion facilitated by
nonallelic tandem repeat sequences has been implicated
in some clustered human gene families, including the
globins (Papadakis and Patrinos 1999) and immuno-
globulins (Sitnikova and Su 1998). Gene conversion in-
volving allelic exchanges is more likely to occur when
the gene in question has a nearby pseudogene or is part
of a gene cluster located on the same chromosome, as
in the HLA genes (Blanco-Gelaz et al. 2001), 21-b hy-
droxylase deficiency (Tusie-Luna and White 1995), and
polycystic kidney disease (Watnick et al. 1998; Bog-
danova et al. 2001). Allelic exchanges are a likely mech-
anism for the DNA rearrangements observed in the
GBA locus.
Although gene conversion cannot easily be distin-
guished from double crossover events, double cross-
overs occurring in very close proximity would not nor-
mally be expected. The sizes of the converted sequences
Figure 3 Illustrations of proposed mechanisms for recombination events occurring between the GBA gene and its pseudogene. A, Allelic gene
conversion. This is a nonreciprocal sequence exchange, facilitated by sequence homology between allelic genes. The donor sequence is unaltered,
but the acceptor sequence is changed by the incorporation of regions copied from the donor sequence. B, Reciprocal crossover between homologous
regions. This event results in two possible gene rearrangements. One is a fusion between the gene and its pseudogene and a deletion of the intergenic
region shown in (1). The second is a partial duplication of the pseudogene and gene sequences, which are fused together (2). C, Holliday model.
This is a mechanism of recombination that includes nicking and reunion between two homologous sequences. Nicking occurs in the same location
in both homologous sequences (i.e., in the GBA gene and pseudogene). Crossover, exchanges, and sealing nicks create chi structures. Branchmigration
and breaking in some base pairs in the four strands increase the chance of bending, rotation, and exchange between strands, resulting in two possible
gene conversion–like alleles (1) and two possible fusion-like alleles (2). Figure adapted fromWeaver andHedrick (1989).D, Intramolecular crossover.
This is another proposed model for recombination between the GBA gene and pseudogene on the same chromosome, resulting in a fusion allele.
In this case, the intergenic region and portions of the gene and pseudogene are removed as an extrachromosomal fragment and are lost.
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identified in this series, ranging from 190 bp to 1,193
bp, are presumably far too short to be the result of a
double crossover. Liskay et al. (1987) demonstrated, in
cultured mammalian cells, that when duplicated chro-
mosomal sequences had regions of shared homology
ranging between 295 bp and 1.8 kb in length, gene
conversion events were efficient, with the rate being di-
rectly proportional to the extent of homology.
Our results demonstrate that the regions where the
GBA gene and pseudogene share the greatest sequence
homology are those with the highest rate of gene con-
version (table 2). The sequence homology shared be-
tween the GBA gene and its pseudogene in the region
between intron 8 and the 3′ UTR is ∼98% and includes
five segments of exact identity, each 1200 bp in length.
The second major type of homologous exchange, re-
ciprocal recombination, can arise by several possible
mechanisms. Gene rearrangement during meiosis or,
rarely, mitosis, can occur by direct crossover between
identical or very similar DNA sequences. This usually
involves the breakage of a pair of homologous chro-
mosomes and a rejoining of the fragments to generate
new recombinant strands.
Tandemly repeated genes or gene clusters are subject
to reciprocal rearrangements leading to disease. For ex-
ample, reciprocal recombination events between the
clustered, highly homologous red and green visual pig-
ment genes at the color vision locus at Xq28 introduce
deletions or fusions, resulting in red/green color blind-
ness (Vollrath et al. 1988; Jagla et al. 2002). In the
thalassemias, crossover between duplicated sequences
at the b-globin gene cluster on 11p15.5 cause the de-
letion of the b gene, resulting in b-thalassemia, while
the same type of crossover in the a-globin gene cluster
on 16p13.3 can cause a-thalassemia (Hattori 1999; Pa-
padakis and Patrinos 1999; Waye et al. 2001). Fusion
genes resulting from unequal crossing over are also seen
in the b-globin gene cluster (Metzenberg et al. 1991).
Reciprocal DNA rearrangements involving LCRs can
cause duplications and deletions associated with dis-
eases. Nonallelic homologous recombination between
two LCRs on 17p12 sharing 98.7% sequence homology
can result in a 1.4-Mb duplication found in Charcot
Marie Tooth disease type IA, and a deletion of the region
causes hereditary neuropathy with liability to pressure
palsies (Lopes et al. 1999; Ji et al. 2000; Hurles 2001;
Stankiewicz and Lupski 2002b). Likewise, recombina-
tion between complex LCRs at the proximal and distal
regions of 17p11.2 can result in the deletion of a 4-Mb
genomic segment in patients with Smith-Magenis syn-
drome or a duplication of the region in patients with
dup(17)(p11.2 p11.2) syndrome (Lucas et al. 2001;
Park et al. 2002b; Shaw et al. 2002).
In a similar fashion, the presence of a pseudogene can
increase the likelihood of reciprocal recombination and,
hence, disease. Unequal crossover or unequal sister
chromatid exchange between a functional gene and a
related pseudogene can result in deletion of the func-
tional gene or the formation of fusion genes carrying a
segment derived from the pseudogene (Purandare and
Patel 1997; Timms et al. 1997; Lobato et al. 1998; Stone
et al. 2000). In steroid 21-hydroxylase deficiency and
Hunter syndrome, most of the mutations arise as a result
of such sequence exchanges between the functional gene
and a very closely related pseudogene (Birot et al. 1996;
Karsten et al. 1997; Bunge et al. 1998; Wedell 1998;
Dracopoulou-Vabouli et al. 2001).
As demonstrated in the present study, recombinations
between the GBA gene and its pseudogene, resulting in
gene fusions or duplications, provide a prime example
of the consequences of reciprocal crossover (fig. 3B).
Fusion alleles with the 5′ sequence deriving from the
gene and 3′ sequence from the pseudogenewere themost
prevalent. Moreover, in several instances, recombina-
tion occurred as a result of crossover between the nearby
gene and pseudogene for MTX.
Another mechanism of recombination demonstrated
in simple organisms that may be relevant to Gaucher
disease is the Holliday junction model, which occurs
during meiosis. In figure 3C, the different steps of the
Holliday model observed in plasmid DNA are shown
(Weaver and Hedrick 1989; Fu et al. 1994). An essential
step in this model occurs when the two homologous
strands cross over and the new branches are sealed by
DNA ligase in a form called the “chi structure” or “half
chiasma.” The branch in the half chiasma can migrate
in either direction simply by breaking old base pairs and
forming new ones. The chi structure is first shown with
two of its strands crossed, but a 180 rotation of either
the upper or the lower uncrossed strands can give rise
to different alleles, such as fusion alleles and gene con-
version–like alleles (a short sequence of the donor strand
can be inserted into an acceptor sequence). TheHolliday
junction mechanism has also been used to explain re-
combinant alleles in yeast (Petes 2001).
A third possible mechanism to explain reciprocal fu-
sions within the GBA locus is intramolecular crossover
(fig. 3D) (Weaver andHedrick 1989).When two regions
sharing similar sequence are located nearby on one
chromosome but are separated by 10 kb, the chance
of an intramolecular crossover with a loop formation
occurring during the cell cycle is increased. As a result,
one daughter cell carries an allele with a fusion between
the gene and pseudogene, and the other daughter cell
carries a small extrachromosomal loop consisting of a
short fragment of gene and pseudogene and the inter-
genic region (fig. 3D).
In higher organisms, clearly one cannot demonstrate
directly whichmechanism occurred during the cell cycle.
However, extrapolating from prokaryotes and yeast,
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several possible mechanisms can be considered. The
gene conversion alleles identified in this study could be
explained either by the classic gene conversion model
or the Holliday junction model. Likewise, the fusion
alleles encountered could arise either by direct crossover,
intramolecular recombination or by the Holliday junc-
tion model.
Crossover hotspot regions in prokaryotes and eukar-
yotes have been analyzed, and some of the factors that
regulate or initiate recombination have been identified
(Bell et al. 1998; Wahls 1998; Petes 2001). In a number
of different human disorders caused by DNA rearrange-
ments, several short DNA sequences or repeat sequences
have been identified at the crossover break points. It is
hypothesized that these sequences might represent amo-
tif that leads to a recombination hotspot (Karsten et al.
1997; Bunge et al. 1998; Aarskog and Vedeler 2001;
Kutsche et al. 2002). The motif sequence (CACCA)
identified in the present study may be helpful in dem-
onstrating other recombination sites in the GBA gene.
Earlier genotype/phenotype studies in Gaucher dis-
ease led to an appreciation that while there are certain
generalizations regarding the ability to predict pheno-
type from genotype, many exceptions remain. On the
basis of the present study, PCR-based genotyping is
clearly not adequate to accurately describe the mutant
alleles in at least 22% of the patients with Gaucher
disease analyzed. This observation is of utmost impor-
tance to laboratories engaged in molecular diagnostics
for Gaucher disease.
Based upon the current genotype/phenotype analyses,
it appears that recombinant alleles are essentially null
alleles. Homozygosity for a recombinant allele results
in very early lethality, usually in utero or in the first
days of life. Genotype L444P/recombinant allele is as-
sociated with classic type 2 Gaucher disease, although
homozygosity for L444P results in a milder phenotype.
Likewise, genotypes V394L/Rec 1a, N188S/Rec 5b, and
N188S/Rec1a were encountered in patients with type 3
Gaucher disease and myoclonic epilepsy, although ho-
mozygosity for V394L and N188S have been seen in
patients with type 1 disease. These examples suggest a
dose response, in which one copy of a point mutation
together with a null allele is more detrimental than two
copies of the missense allele.
The current study demonstrates the frequency and the
type of recombinations in a broad population of pa-
tients with Gaucher disease. Both gene conversion and
reciprocal recombination occur at this locus far more
frequently than previously appreciated. Although it
could not be established whether different mechanisms
or sites of recombination made specific contributions to
phenotype, it can be concluded that a recombinant allele
has a deleterious effect, regardless of how it arose. The
one exception were patients who carried the 3′ dupli-
cation or Rec 7b. While this recombination alone did
not appear to result in Gaucher disease, it still could
potentially have a modifying effect on phenotype.
The region surrounding the human GBA gene on
chromosome 1 is particularly gene rich, with seven
genes and two pseudogenes located within ∼85 kb of
sequence (Winfield et al. 1997). It is particularly inter-
esting to speculate that some of the recombinations oc-
curring within this locus could potentially disrupt other
nearby genes with phenotypic consequences. Certainly,
this gene-rich region provides fertile ground for a deeper
study of the mechanisms of recombination in the human
genome.
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